Avidity Partners Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-222,000
| Closed | -$53.9M | – | 83 |
|
|
2024
Q2 | $53.9M | Sell |
222,000
-21,000
| -9% | -$5.1M | 2.29% | 12 |
|
|
2024
Q1 | $36.3M | Buy |
+243,000
| New | +$36.3M | 1.17% | 30 |
|
|
2022
Q4 | – | Sell |
-288,500
| Closed | -$57.7M | – | 85 |
|
|
2022
Q3 | $57.7M | Buy |
+288,500
| New | +$57.7M | 1.17% | 29 |
|
|
2022
Q1 | – | Sell |
-370,000
| Closed | -$62.7M | – | 93 |
|
|
2021
Q4 | $62.7M | Sell |
370,000
-57,000
| -13% | -$9.67M | 1.33% | 26 |
|
|
2021
Q3 | $80.6M | Buy |
427,000
+232,000
| +119% | +$43.8M | 1.79% | 15 |
|
|
2021
Q2 | $33.1M | Sell |
195,000
-232,969
| -54% | -$39.5M | 0.89% | 41 |
|
|
2021
Q1 | $60.4M | Buy |
+427,969
| New | +$60.4M | 1.67% | 19 |
|